Sichuan Biokin Pharmaceutical Co., Ltd. Class ASSE: 688506

"SICHUAN BIOKIN PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of Approval of the Marketing Application for BL-B01D1/iza-bren for Treatment of Esophageal Cancer

· Issued by Sichuan Biokin Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Approval of the Marketing Application for BL-B01D1/iza-bren for Treatment of Esophageal Cancer

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis